Cargando…
Sphingolipids: the nexus between Gaucher disease and insulin resistance
Sphingolipids constitute a diverse array of lipids in which fatty acids are linked through amide bonds to a long-chain base, and, structurally, they form the building blocks of eukaryotic membranes. Ceramide is the simplest and serves as a precursor for the synthesis of the three main types of compl...
Autor principal: | Fuller, Maria |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964722/ https://www.ncbi.nlm.nih.gov/pubmed/20937139 http://dx.doi.org/10.1186/1476-511X-9-113 |
Ejemplares similares
-
The Link between Gaucher Disease and Parkinson’s Disease Sheds Light on Old and Novel Disorders of Sphingolipid Metabolism
por: Indellicato, Rossella, et al.
Publicado: (2019) -
Defective Sphingolipids Metabolism and Tumor Associated Macrophages as the Possible Links Between Gaucher Disease and Blood Cancer Development
por: Wątek, Marzena, et al.
Publicado: (2019) -
Effects of sphingolipids overload on red blood cell properties in Gaucher disease
por: Dupuis, Lucie, et al.
Publicado: (2020) -
Are Glucosylceramide-Related Sphingolipids Involved in the Increased Risk for Cancer in Gaucher Disease Patients? Review and Hypotheses
por: Dubot, Patricia, et al.
Publicado: (2020) -
Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy
por: Trivedi, Vyoma Snehal, et al.
Publicado: (2022)